Mativ Holdings (FRA:MH2) Research & Development: €20 Mil (TTM As of Mar. 2026)


FRA:MH2 Mativ Holdings Inc FRA:MH2
61 GF Score
Price €7.00
GF Value €10.63
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Mativ Holdings Research & Development?

Mativ Holdings FRA:MH2 61 Research & Development is €20 Mil as of Mar. 2026. GuruFocus rates FRA:MH2 with a GF Score™ of 61/100 and a GF Value™ of €10.63 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mativ Holdings's Research & Development for the three months ended in Mar. 2026 was €5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €20 Mil.

Mativ Holdings  (FRA:MH2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mativ Holdings Research & Development Related Terms

Mativ Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Mativ Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mativ Holdings Research & Development Chart

Mativ Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.44 17.75 19.44 21.97 20.15

Mativ Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.83 5.81 4.77 4.27 4.76
FRA:MH2
61GF Score
Mativ Holdings Inc FRA:MH2
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mativ Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €20 Mil mean?
Mativ Holdings (FRA:MH2) has a Research & Development of €20 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Mativ Holdings and its competitors.
Is Mativ Holdings' Research & Development too high?
Mativ Holdings' current Research & Development is €20 Mil. Overall, Mativ Holdings has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mativ Holdings' Research & Development compare to GEVO and OEC?
Mativ Holdings' Research & Development of €20 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mativ Holdings and its competitors. Mativ Holdings's current Research & Development is €20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mativ Holdings stock overvalued right now?
Based on GuruFocus' analysis, Mativ Holdings (FRA:MH2) is currently considered Possible Value Trap. The stock's GF Value™ is €10.63, compared to a current price of €7.00 — trading 34.1% below its estimated fair value. The current Research & Development is €20 Mil. Mativ Holdings' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mativ Holdings (FRA:MH2), the current Research & Development is €20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mativ Holdings (FRA:MH2) Overvalued in 2026?

Based on GuruFocus' analysis, Mativ Holdings stock appears to be undervalued. The current stock price of €7.00 is trading 34.1% below its estimated GF Value™ of €10.63. GuruFocus considers Mativ Holdings to be Possible Value Trap.

Key valuation signals for FRA:MH2:

  • Research & Development: €20 Mil
  • GF Value™: €10.63 vs. price of €7.00 (34.1% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the FRA:MH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mativ Holdings Business Description

Other Exchanges MATV:USA
Address 100 Kimball Pl, Suite 600, Alpharetta, GA, USA, 30009
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
61GF Score

Get the complete analysis for FRA:MH2

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.00
Price
€10.63
GF Value